Список проголосовавших за комментарий " Gapping up/down: CNYO +8% and KATE +5% on M&A speculation, CSX +1% after upgrade; PETS -3%, HAL and MCD -1% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>: <strong><em>N/A </em></strong><br/> <br/> <strong>M&A news</strong>:</p><ul><li><strong>CYNO</strong> +8.3% (Bloomberg reported co is exploring strategic alternatives)</li><li><strong>KATE</strong> +4.7% (speculation on Friday of possible bidders)</li><li><strong>BNCN</strong> +4.1% (to be acquired by Pinnacle Financial Partners (PNFP))</li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>SBGL</strong> +5.1%, <strong>AU</strong> +3.9%, <strong>VALE</strong> +3.4%, <strong>GOLD</strong> +1.9%, <strong>AG</strong> +1.9%, <strong>AUY</strong> +1.9%, <strong>RIO</strong> +1.6%, <strong>PAAS</strong> +1.4%, <strong>NEM</strong> +1.3%</li><li><strong>ABX</strong> +1.2%, <strong>GDX</strong> +1.1%, <strong>GFI</strong> +0.9%, <strong>BHP</strong> +0.9%, <strong>BBL</strong> +0.8%, <strong>HMY</strong> +0.8%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>MRNS</strong> +31.9% (announces 'positive' prelim data from the initial CDKL5 patients enrolled in its ongoing Phase 2study evaluating ganaxolone as a treatment for orphan, genetic disorders)</li><li><strong>BIOL</strong> +13.6% (confirms 510(k) clearance for commercial distribution in the US of its Epic Pro laser system from the FDA)</li><li><strong>ETRM</strong> +7.9% (continued momentum higher)</li><li><strong>NQ</strong> +4% (enters into non-binding letter of intent for the sale of FL Mobile, announces proposed $100 mln investment at $5.25/share)</li><li><strong>BMY</strong> +0.9% (announces settlement and license agreement with Bristol-Myers (BMY) resolving Keytruda patent litigation; co to make a one-time payment to BMY of $625 mln)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>CSX</strong> +0.9% (upgraded to Outperform from Market Perform at BMO Capital)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>SN</strong> -3.1%, <strong>PETS</strong> -2.7%,<strong>MCD</strong> -0.8%, <strong>HAL</strong> -0.6%</li></ul><p><strong>M&A news</strong>: </p><ul><li><strong>TRGP</strong> -1.7% (acquires Delaware and Midland Basin Assets for $565 mln; commences 7 mln common stock offering), .</li></ul><p><strong>Select oil/gas related names showing early weakness</strong>:</p><ul><li><strong>SDRL</strong> -1.6%, <strong>RIG</strong> -0.9%, <strong>SLB</strong> -0.5%, <strong>HAL</strong> -0.5%, <strong>WLL</strong> -0.5%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>KRNT</strong> -4.5% (public offering of 7 mln ordinary shares by its largest shareholder)</li><li><strong>WGO</strong> -4.4% (files for offering of 4,586,555 shares of common stock by holders)</li><li><strong>QCOM</strong> -3.9% (Apple lawsuit/patent dispute)</li></ul><p><strong>Analyst comments</strong>: <strong><em>N/A</em></strong></p>"